Make a Donation to Cure Addiction Now

Mission Statement

Cure Addiction Now (CAN) is dedicated to the understanding, treatment and ultimate cure of drug addiction. Funding basic research and its clinical translation through a collaborative program is the core focus of the foundation. In addition to creating new therapies to help stop the deadly cycle of addiction, we hope to eliminate the negative stigma of this disease and ultimately find a cure for the brain’s addiction to drugs. Program Goals

Vision Statement

CAN will fund research to develop new therapies to treat the many stages and symptoms of addiction. Detoxing should be accessible and more humane. Research initiatives will study the human brain before and after a person’s onset of addiction to understand how the brain has changed and identify ways to return to a non-dependent state in which an individual can maintain sobriety. It is equally important to create educational campaigns to remove the negative stigma of addiction. We will cure addiction now in our lifetime.

Our collaborative program will link together multidisciplinary scientific and medical expertise to advance the understanding of the causes of addiction. The collaborative goals are simple: communication and cooperation – doctors working together toward a mutual goal. When this goal is reached, all will share in the victory. CAN had cultivated the brightest, most innovative and talented scientists to work as a team and share their research on a monthly basis. Our team currently represents Mount Sinai, Harvard, UCLA, Scripps, University of Washington and Johns Hopkins. Each study will bring unique research ideas to the collaborative group. By constant communication and no duplication of research efforts, we will greatly accelerate the development of new treatments for addiction. Meet our Scientific Advisory Board and Research Scientists


“CAN is a unique consortium that is bringing together some of the best labs in the country to work together to conquer addiction. The CAN labs, by utilizing multidisciplinary approaches in a highly coordinated manner, promise to bring new treatments for drug addiction to the clinic as quickly as possible.”

Eric J. Nestler, M.D., Ph.D.

Nash Family Professor of Neuroscience Director, Friedman Brain Institute Dean for Academic and Scientific Affairs Icahn School of Medicine at Mount Sinai